ALAMANCE REGIONAL MEDICAL CENTER
1. Target Overview & Investment Thesis
ALAMANCE REGIONAL MEDICAL CENTER is a 176-bed suburban community hospital in ALAMANCE, NC with $286.2M in net patient revenue and a 4.8% operating margin. The hospital serves a payer mix of 19.1% Medicare, 4.7% Medicaid, and 76.2% commercial.
Thesis: Undervalued. Our ML models identify $21.1M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from 4.8% to 12.2% (+736bps).
| Net Revenue HCRIS | $286.2M |
| Current EBITDA COMPUTED | $13.8M |
| Operating Margin COMPUTED | 4.8% |
| Occupancy HCRIS | 76.0% |
| Revenue / Bed COMPUTED | $1.6M |
| Net-to-Gross HCRIS | 28.8% |
| Distress Probability ML | 41.4% |
2. Market Context & Competitive Position
NC has 129 Medicare-certified hospitals with a median operating margin of -2.0%. The target's margin of 4.8% places it above the state median. Among 50 size-comparable peers (88-352 beds), the median margin is -1.3%. The target performs in line with or above peers.
3. RCM Performance Analysis — Comparable Hospitals
Comps selected by bed count (88-352), prioritizing same-state peers. 50 hospitals in the comp set.
| Hospital | State | Beds | Revenue | Margin |
|---|---|---|---|---|
| ALAMANCE REGIONAL MEDICAL CENT (Target) | NC | 176 | $286.2M | 4.8% |
| DUKE RALEIGH HOSPITAL | NC | 186 | $683.0M | 3.7% |
| CATAWBA VALLEY MEDICAL CENTER | NC | 200 | $451.9M | 5.9% |
| DUKE REGIONAL HOSPITAL | NC | 301 | $421.0M | -19.8% |
| HIGH POINT MEDICAL CENTER | NC | 288 | $406.1M | 0.3% |
| CAROLINAEAST MEDICAL CENTER | NC | 312 | $365.1M | -2.9% |
| MARGARET R. PARDEE MEMORIAL HO | NC | 160 | $341.3M | -5.7% |
| JOHNSTON HEALTH | NC | 179 | $331.7M | 9.6% |
| NASH HOSPITALS INC | NC | 322 | $320.5M | 12.8% |
4. Predicted Improvement Opportunities
Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $21.1M (736bps margin improvement).
| Lever | Current | Target | EBITDA Impact | Margin | Ramp |
|---|---|---|---|---|---|
| Net Collection Rate | 93.5% | 97.0% | $6.0M | +210bp | 18mo |
| Cost to Collect | 4.5% | 2.5% | $5.7M | +200bp | 12mo |
| Denial Rate Reduction | 12.0% | 6.5% | $5.7M | +198bp | 12mo |
| A/R Days Reduction | 5200.0% | 3800.0% | $3.5M | +122bp | 9mo |
| Clean Claim Rate | 88.0% | 96.0% | $183K | +6bp | 6mo |
5. EBITDA Bridge
| Current EBITDA | $13.8M |
| + RCM Uplift | +$21.1M |
| Pro Forma EBITDA | $34.8M |
| Current Margin | 4.8% |
| Pro Forma Margin | 12.2% |
| WC Released (1x) | $11.0M |
6. Returns Analysis — Scenario Matrix
5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.
| Scenario | Entry | Exit | Equity In | Equity Out | MOIC | IRR |
|---|---|---|---|---|---|---|
| Base Case | 10.0x | 10.0x | $21.2M | $301.4M | 14.25x | 70.1% |
| Base (11x exit) | 10.0x | 11.0x | $21.2M | $338.4M | 16.00x | 74.1% |
| Bull Case | 9.0x | 11.0x | $19.0M | $414.8M | 21.79x | 85.2% |
| Bull (12x exit) | 9.0x | 12.0x | $19.0M | $458.1M | 24.06x | 88.9% |
| Bear Case | 11.0x | 10.0x | $23.3M | $189.2M | 8.13x | 52.1% |
| Bear (11x exit) | 11.0x | 11.0x | $23.3M | $215.7M | 9.27x | 56.1% |
7. Key Risks & Mitigants
| Severity | Risk Factor | Mitigant |
|---|---|---|
| Medium | Standard execution risk | RCM improvement requires management buy-in and 12-18 month implementation timeline |
8. Data Sources & Methodology Appendix
Data Sources
- CMS HCRIS Cost Reports (Medicare-certified hospitals)
- CMS Medicare Utilization (DRG-level volumes)
- CMS Chronic Conditions (county-level disease prevalence)
- HCRIS multi-year trend data (financial time series)
Comparable Selection
- 50 hospitals with 88-352 beds
- Same-state prioritization (n=51)
- Comp margins: P25=-8.0% / P50=-1.3% / P75=8.9%
Bridge Methodology
- Targets: P75 of comparable peers (60% gap closure)
- Denial: avoidable share = 35% of delta × NPR
- AR: bad debt coefficient = $0.65 per day per $1K NPR
- NCR: 60% coefficient on collection rate improvement
- CDI: 0.75% of Medicare revenue per 0.01 CMI point
Returns Assumptions
- Leverage: 5.5x entry (84.6% debt / 15.4% equity)
- Organic growth: 3% annual EBITDA growth
- Debt paydown: 10% of principal per year
- Hold period: 5 years
Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.